发明名称 CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF UVEITIS
摘要 This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polymer such as e.g. polylactic-coglycolic acid.
申请公布号 US2016106717(A1) 申请公布日期 2016.04.21
申请号 US201514884514 申请日期 2015.10.15
申请人 Gen Pharma Holdings LLC 发明人 Gupta Sunil
分类号 A61K31/4192;A61K45/06;A61K31/573;A61K47/48;A61K47/34;A61K9/00 主分类号 A61K31/4192
代理机构 代理人
主权项 1. A method of treating uveitis in a patient comprising administering to the patient a sustained-release system comprising a pharmaceutically effective amount of 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) (CAI).
地址 Pensacola FL US